Rep. Darrell Issa (R-CA) Discusses Trade Secrets with the FDA

DATE: March 5, 2014 | Andre Francisco

Topics: Whistleblower Protections | Related Content: Food and Drug Administration

From a hearing on the FDA's surveillance of whistleblowers in front of the House Oversight and Government Reform Committee.

For more information, see Angela Canterbury's full written testimony and our blog post about the hearing.

comments powered by Disqus

Related Work